Clinical Trial Update: Benzydamine Oromucosal Solution in Oral Mucositis (BOOM) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for benzydamine oromucosal solution in Radiation-Induced Mucositis associated with head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Radiation-induced Mucositis

Drugs mentioned

• Benzydamine Oromucosal Solution (benzydamine)

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Radiation-Induced Mucositis, Head and Neck Cancer | Phase 4 | Status: COMPLETED